NIFTY 50▲24,586.45
180.35 (0.74%)
SENSEX▲80,568.23
528.43 (0.66%)
NIFTY BANK▼50,746.60
-142.15 (-0.28%)
INDIAN RAILWAY FINANCE CORP▼183.03
-0.53 (-0.29%)
TATA MOTORS▼1,085.50
-5.45 (-0.50%)
TATA STEEL▲160.90
3.51 (2.23%)
TATA POWER▲438.20
14.85 (3.51%)
SUZLON ENERGY▲62.83
1.36 (2.21%)
RAIL VIKAS NIGAM▼561.65
-14.05 (-2.44%)
INDIAN RENEWABLE ENERGY▲263.35
2.17 (0.83%)
VODAFONE IDEA▲15.84
0.66 (4.35%)
RELIANCE INDUSTRIES▲3,011.00
26.20 (0.88%)
YES BANK▲24.79
0.17 (0.69%)
ADANI POWER▲702.30
7.10 (1.02%)
NHPC▲104.72
2.76 (2.71%)
STATE BANK OF INDIA▲854.65
6.15 (0.72%)
HDFC BANK▼1,598.75
-17.85 (-1.10%)
RELIANCE POWER▼29.55
-0.14 (-0.47%)
JIO FIN SERVICES LTD▲335.00
5.80 (1.76%)
ZOMATO▲220.12
0.81 (0.37%)
ADANI PORT & SEZ▲1,505.00
18.00 (1.21%)
BHARAT ELECTRONICS▲307.75
6.30 (2.09%)
INDIAN RAILWAY TOURISM CORP▲976.60
7.45 (0.77%)
INDIAN OIL CORP▲177.35
0.50 (0.28%)
RATTANINDIA POWER▲16.86
0.05 (0.30%)
MRF▲1,37,599.95
9.85 (0.01%)
ADANI ENTERPRISES▲3,008.90
35.40 (1.19%)
JAIPRAKASH POWER VENTURES▲19.10
0.27 (1.43%)
![stock logo](https://assets.upstox.com/content/assets/images/logos/NSE_EQ|INE082A01010.png)
Kopran Share Price
KOPRAN
₹258.05-₹0.70 (-0.27%) TodayLast updated on 26 Jul, 2024 | 10:23 IST
₹256.00₹260.00
L
H
What’s in news?
Company overview
Financial performance
Market cap
| Open₹258.70 | Close₹258.75 |
Circuit range₹310.50 - ₹207.00 | Day range₹256.00 - ₹260.00 | Year range₹159.70 - ₹292.30 |
Volume86,265 | Avg. traded₹258.66 | Revenue (12m)₹615 Crs |
KopranKopran Limited is an India-based integrated pharmaceutical company. The Company is primarily engaged in the business of manufacturing of formulation (finished dosage form) and active pharmaceutical ingredients (APIs). Its formulations product categories include penicillin-based finished oral dosage forms and non-penicillin-based finished oral dosage forms. The Company's penicillin-based finished oral dosage forms include anti-infective, amoxycillin, ampicillin, cloxacillin and amoxy clauv. Its non-penicillin-based finished oral dosage forms include macrolides, anti-hypertensive, cardiovascular, anti-helmentics, antihistamine, anti-diabetic, pain management and gastroenterology. It provides ingredients in a wide range of pharmaceutical products, such as capsules, injectables and tablets, among others. The Company's APIs products include anti-hypertensive, macrolides, neuromodulator, urological, anti-infective/anti-acne, sterile carbapenems and sterile cephalosporins.
Kopran Key indicators
52 week high₹292.30 | 52 week low₹159.70 | P/E ratio22.34 |
P/B ratio2.44 | ROE8.07% | ROCE9.44% |
Dividend yield1.16% | Debt/Equity ratio0.07 | EPS6.48 |
Learn more
Featured in
Investment checklist: (3/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Fundamentals
Financial ratios
Operating profit margin16.11% | Net profit margin11.44% |
ROE8.07% | ROA6.44% |
ROCE9.44% |
Learn more
Kopran Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Thu, Jul 25 2024 | ₹253.00 | ₹258.75 | |
Wed, Jul 24 2024 | ₹234.95 | ₹254.65 | |
Tue, Jul 23 2024 | ₹237.75 | ₹234.60 | -0.82% |
Mon, Jul 22 2024 | ₹238.90 | ₹236.55 | -1.21% |
Fri, Jul 19 2024 | ₹247.75 | ₹239.45 | -3.56% |
Thu, Jul 18 2024 | ₹253.65 | ₹248.30 | -2.13% |
Tue, Jul 16 2024 | ₹254.80 | ₹253.70 | -0.08% |
Mon, Jul 15 2024 | ₹255.45 | ₹253.90 | -0.61% |
Events
Corporate actions
Dividend • ₹3/share
Ex date 07 Sep 2023
Dividend • ₹3/share
Ex date 04 Aug 2022
Dividend • ₹3/share
Ex date
Learn more